Abeona Therapeutics Inc. (ABEO) short interest & options flow
NASDAQAbeona Therapeutics delivered a clean Q1 earnings beat this morning, but the short side is not moving. Revenue of $8.72M crushed the $4.57M consensus by a wide margin. EPS came in at -$0.30, five cents better than the -$0.35 estimate. Management reported continued expansion of its pz-cel treatment center network — the key commercial driver for its FDA-approved cell therapy for…
- Market cap
- $140M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026

ABEO news and analysis
RSSNo long-form analysis yet for ABEO. Pulse alerts and the live data picture are available on ORTEX.
Open ABEO on ORTEX →Want the live picture for ABEO?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABEO — free to start on ORTEX.
Sign up for free →Open ABEO on ORTEX